Ardent Health, Inc. (NYSE:ARDT) Receives Average Recommendation of "Moderate Buy" from Analysts

Key Points

• Analysts have given Ardent Health, Inc. (NYSE: ARDT) an average recommendation of "Moderate Buy," with eight brokerage firms rating it a buy, one hold, and one sell.
• The average target price for Ardent Health shares among analysts is $19.56, while Royal Bank of Canada has set a higher price target of $21.00.
• Recently reported earnings showed Ardent Health beating consensus estimates with $0.52 EPS and revenues of $1.65 billion for the quarter, surpassing expectations.

Shares of Ardent Health, Inc. (NYSE:ARDT - Get Free Report) have been assigned an average rating of "Moderate Buy" from the ten brokerages that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $19.56.

Several research firms have recently weighed in on ARDT. Royal Bank Of Canada restated an "outperform" rating and set a $21.00 price objective on shares of Ardent Health in a research note on Thursday, May 15th. KeyCorp dropped their target price on Ardent Health from $24.00 to $20.00 and set an "overweight" rating for the company in a report on Thursday, August 7th. Guggenheim boosted their price target on Ardent Health from $16.00 to $18.00 and gave the company a "buy" rating in a research note on Friday, May 9th. Stephens reaffirmed an "overweight" rating and set a $21.00 price objective on shares of Ardent Health in a research report on Tuesday, May 20th. Finally, Bank of America cut Ardent Health from a "neutral" rating to an "underperform" rating and cut their target price for the stock from $15.50 to $14.60 in a research note on Wednesday, July 16th.

Ardent Health Stock Performance

Shares of ARDT opened at $12.76 on Friday. The stock has a market capitalization of $1.83 billion and a price-to-earnings ratio of 7.05. The firm has a fifty day simple moving average of $12.41 and a 200 day simple moving average of $13.34. The company has a current ratio of 2.13, a quick ratio of 2.00 and a debt-to-equity ratio of 0.66. Ardent Health has a 12 month low of $10.10 and a 12 month high of $20.72.

Ardent Health (NYSE:ARDT - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.30 by $0.22. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. Research analysts forecast that Ardent Health will post 1.23 EPS for the current fiscal year.

Institutional Investors Weigh In On Ardent Health

Several hedge funds have recently modified their holdings of ARDT. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Ardent Health in the 4th quarter valued at about $27,000. CWM LLC raised its position in shares of Ardent Health by 990.6% during the second quarter. CWM LLC now owns 2,203 shares of the company's stock worth $30,000 after acquiring an additional 2,001 shares during the last quarter. Morse Asset Management Inc acquired a new position in shares of Ardent Health in the first quarter worth approximately $36,000. Deutsche Bank AG boosted its holdings in Ardent Health by 1,251.9% in the fourth quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock valued at $49,000 after acquiring an additional 2,654 shares during the last quarter. Finally, Quarry LP increased its position in Ardent Health by 1,519.4% during the 1st quarter. Quarry LP now owns 5,020 shares of the company's stock valued at $69,000 after purchasing an additional 4,710 shares during the period.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.